Page 11 - Christiana Care Health System Focus September 2018

| The Value Institute Frontiers of medicine
in Delaware
gene editing, smart medications and ZNA
19803
19711
19714
19806
19734
19904
19953
On an early Tuesday morning
in July, more than 100 people gathered at the John H. Ammon Medical Education Center at Christiana Hospital to hear about such eye-opening advances in bioscience and health care as:
• A gene-editing technology that helps improve cancer treatments.
• Digital pills that send data to an iPad app.
• The effect your ZIP code has on your health.
These topics and more were covered during the Delaware BioScience Association’s July 17 BioBreakfast, titled “Connectivity & Collaborations.”
Christiana Care was an apt host for
an event highlighting collaboration. Christiana Care’s Value Institute is a
hub of research activities in the health system, said Scott D. Siegel, Ph.D., director of Population Health and Community- Based Research, which is part of the Value Institute.
The Value Institute also creates partnerships with organizations including patient advocacy groups, industry and academic institutions, and national and international health care systems.
“We’re here to develop, deliver and evaluate innovative solutions that impact population health, patient experience, system perfor- mance and policy development,” Siegel said at the start of the BioBreakfast program.
A
F. Graham Cancer Center & Research Institute, and NovellusDx. Based in Israel, NovellusDx provides oncology professionals with the data and insights needed to create a precise, personalized treatment plan for eachpatient. CONTINUED
nother example of collaboration is between the Gene Editing Institute, which is embedded
in Christiana Care’s Helen
FOCUS • SEPTEMBER 2018 9